Prevalence of Weight Related Complications Across Diverse Weight Classifications - A Large Study in India, Pakistan, Philippines and Vietnam
WEIGHT DIVERSE
2 other identifiers
observational
1,170
4 countries
4
Brief Summary
This study is investigating how common weight related health problems are in people of different weight categories in India, Pakistan, Philippines, and Vietnam. The purpose of the study is to understand the prevalence of weight related health problems in different weight groups. Participants will continue their normal care and will not get any treatment as part of this study; participants will continue receiving any treatments their doctor has prescribed. The study will last for about 2 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2025
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2025
CompletedFirst Posted
Study publicly available on registry
February 25, 2025
CompletedStudy Start
First participant enrolled
March 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 11, 2025
CompletedApril 8, 2026
April 1, 2026
7 months
February 20, 2025
April 7, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of Weight-Related Complications Across Different Body Mass Index (BMI) Classes
Percentage (%)
Upon data collection (Day 1)
Study Arms (1)
Cohort 1
Participants will be assessed for obesity-related complications, including measurement of Body Mass Index (BMI)
Interventions
Eligibility Criteria
Participants will be assessed for obesity-related complications, including measurement of Body Mass Index (BMI)
You may qualify if:
- Informed consent obtained before any study related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male or female aged 18 years or older at the time of signing informed consent.
- Presence of at least one Weight-related complication.
You may not qualify if:
- Participants less than 18 years of age at the time of signing informed consent.
- Pregnant women and individuals with recent weight loss due to illness, defined as more than 5 percent (%) weight loss in the past 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Novo Nordisk A/Slead
Study Sites (4)
AIIMS,Delhi
New Delhi, National Capital Territory of Delhi, 110029, India
National Hospital Lahore
Lahore, 54810, Pakistan
Asian Hospital and Medical Center
Metro Manila, San Juan, 1502, Philippines
Tam Anh TP. Ho Chi Minh General Hospital
Ho Chi Minh City, Tan Binh, 700000, Vietnam
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Clinical Transparency (dept. 2834)
Novo Nordisk A/S
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2025
First Posted
February 25, 2025
Study Start
March 18, 2025
Primary Completion
October 11, 2025
Study Completion
October 11, 2025
Last Updated
April 8, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
According to the Novo Nordisk disclosure commitment on novonordisk-trials.com